20 related articles for article (PubMed ID: 2469699)
1. Preparation and characterization of polyclonal and monoclonal antibodies against human interleukin 1 alpha (IL 1 alpha).
Kasahara T; Mukaida N; Shinomiya H; Imai M; Matsushima K; Wakasugi H; Nakano K
J Immunol; 1987 Mar; 138(6):1804-12. PubMed ID: 3546497
[TBL] [Abstract][Full Text] [Related]
2. Generation of monoclonal antibodies to murine IL-1 beta and demonstration of IL-1 in vivo.
Hogquist KA; Nett MA; Sheehan KC; Pendleton KD; Schreiber RD; Chaplin DD
J Immunol; 1991 Mar; 146(5):1534-40. PubMed ID: 1993843
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies to human recombinant interleukin 1 (IL 1)beta: quantitation of IL 1 beta and inhibition of biological activity.
Kenney JS; Masada MP; Eugui EM; Delustro BM; Mulkins MA; Allison AC
J Immunol; 1987 Jun; 138(12):4236-42. PubMed ID: 2438338
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of two neutralizing monoclonal antibodies to human interleukin-1 alpha.
Stya M; Dower SK; Prickett KS; Gillis S; Conlon PJ
J Biol Response Mod; 1988 Apr; 7(2):162-72. PubMed ID: 3258906
[TBL] [Abstract][Full Text] [Related]
5. Development and use of a radioimmunoassay for human interleukin-1 beta.
Lisi PJ; Chu CW; Koch GA; Endres S; Lonnemann G; Dinarello CA
Lymphokine Res; 1987; 6(3):229-44. PubMed ID: 3498100
[TBL] [Abstract][Full Text] [Related]
6. Distinct patterns of IL-1 alpha and IL-1 beta organ distribution--a possible basis for organ mechanisms of innate immunity.
Hacham M; Argov S; White RM; Segal S; Apte RN
Adv Exp Med Biol; 2000; 479():185-202. PubMed ID: 10897420
[No Abstract] [Full Text] [Related]
7. Preparation and application of polyclonal antibodies to recombinant human interleukin-1 alpha and interleukin-1 beta.
Cornette JC; Sharma SK
J Immunoassay; 1989; 10(1):107-24. PubMed ID: 2469699
[TBL] [Abstract][Full Text] [Related]
8. Antibodies and their role in interleukin-1 research.
Gaffney EV; Anderson AE; Pfanenstiel YT; Koch GA
Immunol Rev; 1991 Feb; 119():181-201. PubMed ID: 2045120
[TBL] [Abstract][Full Text] [Related]
9. Opposing effects of IL-1 alpha and IL-1 beta on malignancy patterns. Tumor cell-associated IL-1 alpha potentiates anti-tumor immune responses and tumor regression, whereas IL-1 beta potentiates invasiveness.
Apte RN; Dvorkin T; Song X; Fima E; Krelin Y; Yulevitch A; Gurfinkel R; Werman A; White RM; Argov S; Shendler Y; Bjorkdahl O; Dohlsten M; Zoller M; Segal S; Voronov E
Adv Exp Med Biol; 2000; 479():277-88. PubMed ID: 10897428
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
